TREPROSTINIL-PRODRUGS
European patent · EP3515430 · In force
Register entry
- Publication number
- EP3515430
- Application number
- EP17785072
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 26, 2017
- Published
- Jul 31, 2019
- Granted
- Sep 2, 2026
- Protection ends at the latest
- Sep 25, 2037
- Next annual fee due
- Sep 30, 2026
- IPC classes
- A61K 31/216 (2006.01)A61K 31/222 (2006.01)A61K 31/335 (2006.01)A61K 31/192 (2006.01)A61K 31/265 (2006.01)A61K 31/27 (2006.01)A61P 9/12 (2006.01)
- Priority
- US 201662399737 P 26.09.2016
- PCT application
- PCT/US2017/053503 26.09.2017
- PCT publication
- WO2018/058124 29.03.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 2, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.09.2026
Parties
Inventor
PHARES, Ken
Hillsborough, NC 27278, US
BATRA, Hitesh
Herndon, VA 20171, US
GUO, Liang
Vienna, VA 22182, US
SILVERSTEIN, Adam, Marc
Cary, NC 27519, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.